It was demonstrated that Slit2/ROBO1 signaling prevented glioma cell motility and invasion by inactivating Cdc42-GTP, even though the precise mechanisms behind this tumor-suppressive gene impact of Slit2/ROBO1 remain unknown [13]. The gene discussed is SLIT2; the disease is central nervous system cancer.